The natural flavonoid apigenin sensitizes human CD44 + prostate cancer stem cells to cisplatin therapy

Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, 136, E359, 10.1002/ijc.29210 Feldman, 2001, The development of androgen-independent prostate cancer, Nat. Rev. Cancer, 1, 34, 10.1038/35094009 Grasso, 2012, The mutational landscape of lethal castration-resistant prostate cancer, Nature, 487, 239, 10.1038/nature11125 Vinogradov, 2012, Cancer stem cells and drug resistance: the potential of nanomedicine, Nanomedicine, 7, 597, 10.2217/nnm.12.22 Yang, 2016, Cancer stem cells, metabolism, and therapeutic significance, Tumor Biol., 37, 5735, 10.1007/s13277-016-4945-x Reya, 2001, Stem cells, cancer, and cancer stem cells, Nature, 414, 105, 10.1038/35102167 Peiris-Pages, 2016, Cancer stem cell metabolism, Breast Cancer Res., 18, 55, 10.1186/s13058-016-0712-6 Yoshida, 2016, Therapeutic strategies targeting cancer stem cells, Cancer Sci., 107, 5, 10.1111/cas.12817 Ishimoto, 2011, CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(−) and thereby promotes tumor growth, Cancer Cell, 19, 387, 10.1016/j.ccr.2011.01.038 Wu, 2015, TPO-Induced metabolic reprogramming drives liver metastasis of colorectal cancer CD110+tumor-initiating cells, Cell Stem Cell, 17, 47, 10.1016/j.stem.2015.05.016 Sharpe, 2013, Searching for prostate cancer stem cells: markers and methods, Stem Cell Rev. Rep., 9, 721, 10.1007/s12015-013-9453-4 Dasari, 2014, Cisplatin in cancer therapy: molecular mechanisms of action, Eur. J. Pharmacol., 740, 364, 10.1016/j.ejphar.2014.07.025 Jamieson, 1999, Structure, recognition, and processing of cisplatin-DNA adducts, Chem. Rev., 99, 2467, 10.1021/cr980421n Fantini, 2015, In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment, Int. J. Mol. Sci., 16, 9236, 10.3390/ijms16059236 Kumar, 2013, Chemistry and biological activities of flavonoids: an overview, Sci. World J., 2013, 10.1155/2013/162750 Patel, 2007, Apigenin and cancer chemoprevention: progress, potential and promise (Review), Int. J. Oncol., 30, 233 Fang, 2005, Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways, FASEB J., 19, 342, 10.1096/fj.04-2175com Shukla, 2010, Apigenin: a promising molecule for cancer prevention, Pharm. Res.-Dordr., 27, 962, 10.1007/s11095-010-0089-7 Shukla, 2014, Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway, Carcinogenesis, 35, 452, 10.1093/carcin/bgt316 Tong, 2013, Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention, Anti-Cancer Agent Med. Chem., 13, 971, 10.2174/18715206113139990119 Hessenauer, 2003, Inhibition of CK2 activity provokes different responses in hormone-sensitive and hormone-refractory prostate cancer cells, Int. J. Oncol., 22, 1263 Wang, 2013, Apigenin suppresses migration and invasion of transformed cells through down-regulation of C-X-C chemokine receptor 4 expression, Toxicol. Appl. Pharm., 272, 108, 10.1016/j.taap.2013.05.028 Shukla, 2004, Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells, Mol. Carcinogen., 39, 114, 10.1002/mc.10168 Erdogan, 2016, The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-kappaB signaling, Life Sci., 162, 77, 10.1016/j.lfs.2016.08.019 Fulda, 2013, Regulation of apoptosis pathways in cancer stem cells, Cancer Lett., 338, 168, 10.1016/j.canlet.2012.03.014 Krause, 2016, Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments, Adv. Drug Deliv. Rev. Ju, 2015, The flavonoid apigenin ameliorates cisplatin-Induced nephrotoxicity through reduction of p53 activation and promotion of PI3 K/Akt pathway in human renal proximal tubular epithelial cells, Evid.-Based Compl. Alt., 2015, 9, 10.1155/2015/186436 He, 2016, Protective role of apigenin in cisplatin-induced renal injury, Eur. J. Pharmacol., 789, 215, 10.1016/j.ejphar.2016.07.003 Chan, 2012, Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin, Biochim. Biophys. Acta, 1820, 1081, 10.1016/j.bbagen.2012.04.013 Caltagirone, 2000, Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential, Int. J. Cancer, 87, 595, 10.1002/1097-0215(20000815)87:4<595::AID-IJC21>3.0.CO;2-5 Johnson, 2013, Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro, Food Chem. Toxicol., 60, 83, 10.1016/j.fct.2013.07.036 Choi, 2009, Apigenin induces apoptosis through a mitochondria/caspase-pathway in human Breast cancer MDA-MB-453Cells, J. Clin. Biochem. Nutr., 44, 260, 10.3164/jcbn.08-230 Jung, 2010, Newly identified tumor-associated role of human Sharpin, Mol. Cell. Biochem., 340, 161, 10.1007/s11010-010-0413-x Li, 2015, SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP DU145 and PC-3 cells via NF-kappaB/ERK/Akt signaling pathway, Med. Oncol., 32, 444, 10.1007/s12032-014-0444-3 Bragado, 2007, Apoptosis by cisplatin requires p53 mediated p38 alpha MAPK activation through ROS generation, Apoptosis, 12, 1733, 10.1007/s10495-007-0082-8 Baharuddin, 2016, Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines, Oncol. Rep., 35, 13, 10.3892/or.2015.4371 Wang, 2014, Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/beta-catenin/Snail signaling pathway, Eur. J. Pharmacol., 723, 156, 10.1016/j.ejphar.2013.12.004 Thiery, 2009, Epithelial-Mesenchymal transitions in development and disease, Cell, 139, 871, 10.1016/j.cell.2009.11.007 Qin, 2016, Apigenin inhibits NF-kappaB and snail signaling, EMT and metastasis in human hepatocellular carcinoma, Oncotarget, 7, 10.18632/oncotarget.9404 Hossini, 2016, PI3 K/AKT signaling pathway is essential for survival of induced pluripotent stem cells, PLoS One, 11, 10.1371/journal.pone.0154770 Qi, 2001, Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase zeta. Mitogen-activated protein kinase, and phosphatidylinositol 3-kinase, J. Biol. Chem., 276, 15868, 10.1074/jbc.M005911200 Chalhoub, 2009, PTEN and the PI3-kinase pathway in cancer, Annu. Rev. Pathol., 4, 127, 10.1146/annurev.pathol.4.110807.092311 Virtakoivu, 2012, Distinct roles of AKT isoforms in regulating beta1-integrin activity, migration, and invasion in prostate cancer, Mol. Biol. Cell, 23, 3357, 10.1091/mbc.E12-03-0213